(Q40523698)

English

Treatment of metastatic carcinoid tumors using multimodality therapy of octreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization

scientific article published on May 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

Treatment of metastatic carcinoid tumors using multimodality therapy of octreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

carcinoid tumor

1 reference

based on heuristic

inferred from title

author name string

Diaco DS

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Hajarizadeh H

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Mueller CR

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Fletcher WS

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Pommier RF

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Woltering EA

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 May 1995

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

The American Journal of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

169

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

523-528

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2980210-4

7 January 2021

The carcinoid syndrome: palliation by hepatic artery embolization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2980210-4

7 January 2021

Malignant rectal carcinoid: a sequential multidisciplinary approach for successful treatment of hepatic metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2980210-4

7 January 2021

Evaluation of temporary liver dearterialization and embolization in patients with metastatic carcinoid tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2980210-4

7 January 2021

Embolization of the liver in the management of metastatic carcinoid tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2980210-4

7 January 2021

Hepatic arterial embolization for metastatic hormone-secreting tumors. Technique, effectiveness, and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2980210-4

7 January 2021

Effective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2980210-4

7 January 2021

Recombinant alpha-2 interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2980210-4

7 January 2021

Treatment of carcinoid liver metastases by hepatic-artery embolisation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2980210-4

7 January 2021

Metastatic carcinoid tumors and the malignant carcinoid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2980210-4

7 January 2021

The management of patients with advanced carcinoid tumors and islet cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2980210-4

7 January 2021

Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2980210-4

7 January 2021

The carcinoid flush. Provocation by pentagastrin and inhibition by somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2980210-4

7 January 2021

Somatostatin analogue phase I trials in neuroendocrine neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2980210-4

7 January 2021

Identifiers

10.1016/S0002-9610(99)80210-4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40523698&oldid=2138631030"